デフォルト表紙
市場調査レポート
商品コード
1293632

抗生物質市場:作用機序別、薬物クラス別、薬効範囲別-2023~2030年の世界予測

Antibiotics Market by Action Mechanism, Drug Class, Spectrum - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
抗生物質市場:作用機序別、薬物クラス別、薬効範囲別-2023~2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗生物質市場は、2023年にCAGR 6.47%で420億6,000万米ドル、2030年には653億7,000万米ドルに達すると予測され、大きく成長すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の抗生物質市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:ロシア・ウクライナ紛争、高インフレに関する包括的な理解を提供します。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.抗生物質の世界市場規模および予測は?

2.予測期間中、世界の抗生物質市場を形成するCOVID-19の阻害要因と影響は?

3.抗生物質の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.抗生物質の世界市場における競争戦略は?

5.抗生物質の世界市場における技術動向と規制の枠組みは?

6.抗生物質の世界市場における主要ベンダーの市場シェアは?

7.抗生物質の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 感染症患者の増加
      • 新しい抗生物質と多数の臨床試験のための新しい戦略の開発
      • 低・中所得国における消費の拡大
    • 抑制要因
      • 抗生物質の悪用
    • 機会
      • 抗生物質耐性微生物感染症を治療するための先進的な有望分子と新規併用療法
      • 新薬の研究開発と投資が拡大
    • 課題
      • 抗生物質の使用別引き起こされる副作用
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 抗生物質市場:作用機序別

  • イントロダクション
  • 細胞壁合成阻害剤
  • DNA合成阻害剤
  • ミコール酸阻害剤
  • タンパク質合成阻害剤
  • RNA合成阻害剤

第7章 抗生物質市場:薬物クラス別

  • イントロダクション
  • アミノグリコシド
  • カルバペネム
  • セファロスポリン
  • フルオロキノロン
  • マクロライド系
  • ペニシリン
  • スルホンアミド

第8章 抗生物質市場:薬効範囲別

  • イントロダクション
  • 広域の抗生物質
  • 狭域の抗生物質

第9章 南北アメリカの抗生物質市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の抗生物質市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの抗生物質市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ANTIBIOTICS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIBIOTICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2022 VS 2030 (%)
  • FIGURE 5. ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
  • FIGURE 6. ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2022 VS 2030 (%)
  • FIGURE 7. ANTIBIOTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. ANTIBIOTICS MARKET DYNAMICS
  • FIGURE 9. ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 5. ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 11. ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 19. ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 148. ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 149. ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 150. ANTIBIOTICS MARKET LICENSE & PRICING
目次
Product Code: MRR-434CCDA05131

The Global Antibiotics Market is forecasted to grow significantly, with a projected USD 42.06 billion in 2023 at a CAGR of 6.47% and expected to reach a staggering USD 65.37 billion by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Antibiotics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Antibiotics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Action Mechanism, market is studied across Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors. The Mycolic Acid Inhibitors is projected to witness significant market share during forecast period.

Based on Drug Class, market is studied across Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, Macrolides, Penicillin, and Sulfonamides. The Fluoroquinolone is projected to witness significant market share during forecast period.

Based on Spectrum, market is studied across Broad-spectrum Antibiotics and Narrow-spectrum Antibiotics. The Broad-spectrum Antibiotics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific commanded largest market share of 38.10% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Antibiotics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Antibiotics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antibiotics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antibiotics Market?

4. What is the competitive strategic window for opportunities in the Global Antibiotics Market?

5. What are the technology trends and regulatory frameworks in the Global Antibiotics Market?

6. What is the market share of the leading vendors in the Global Antibiotics Market?

7. What modes and strategic moves are considered suitable for entering the Global Antibiotics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Antibiotics Market, by Action Mechanism, 2022 vs 2030
  • 4.3. Antibiotics Market, by Drug Class, 2022 vs 2030
  • 4.4. Antibiotics Market, by Spectrum, 2022 vs 2030
  • 4.5. Antibiotics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Patients Suffering from Infectious Diseases
      • 5.1.1.2. Development of Novel Strategies for New Antibiotics and a Large Number of Clinical Trials
      • 5.1.1.3. Extended Consumption in Low and Middle-Income Countries
    • 5.1.2. Restraints
      • 5.1.2.1. Misuse of Antibiotics
    • 5.1.3. Opportunities
      • 5.1.3.1. Advanced Prospect Molecules and Novel Combination Therapies to Treat Antibiotic-Resistant Microbial Infections
      • 5.1.3.2. Growing in R&D and Investments for New Drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Side Effects Caused by the Usage of Antibiotic Drugs
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Antibiotics Market, by Action Mechanism

  • 6.1. Introduction
  • 6.2. Cell Wall Synthesis Inhibitors
  • 6.3. DNA Synthesis Inhibitors
  • 6.4. Mycolic Acid Inhibitors
  • 6.5. Protein Synthesis Inhibitors
  • 6.6. RNA Synthesis Inhibitors

7. Antibiotics Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Aminoglycosides
  • 7.3. Carbapenem
  • 7.4. Cephalosporin
  • 7.5. Fluoroquinolone
  • 7.6. Macrolides
  • 7.7. Penicillin
  • 7.8. Sulfonamides

8. Antibiotics Market, by Spectrum

  • 8.1. Introduction
  • 8.2. Broad-spectrum Antibiotics
  • 8.3. Narrow-spectrum Antibiotics

9. Americas Antibiotics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Antibiotics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Antibiotics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

1. Abbott Laboratories

2. Akron Incorporated

3. Amneal Pharmaceuticals LLC

4. Astellas Pharma, Inc.

5. Bausch Health Companies, Inc.

6. Bayer AG

7. Bristol-Myers Squibb Company

8. Cadila Healthcare Ltd.

9. Eli Lilly and Company

10. F. Hoffmann-La Roche AG

11. Johnson & Johnson

12. KYORIN Holdings, Inc.

13. LG Chem Ltd.

14. Lupin Limited

15. Melinta Therapeutics, Inc.

16. Merck & Co., Inc.

17. MerLion Pharmaceuticals GmbH

18. Mylan N.V.

19. Novartis International AG

20. Pfizer Inc.

21. Sanofi S.A.

22. Shionogi & Co., Ltd.

23. Sun Pharmaceutical Industries Limited

24. Teva Pharmaceutical Industries Ltd.